Robert G Weaver1, Matthew T James1,2, Pietro Ravani1,2, Colin G W Weaver2, Edmund J Lamb3, Marcello Tonelli1, Braden J Manns1,2, Robert R Quinn1, Min Jun4, Brenda R Hemmelgarn5,2. 1. Departments of Medicine and. 2. Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada. 3. Pathology Department, Clinical Biochemistry, East Kent Hospitals University National Health Service Trust, Canterbury, Kent, United Kingdom; and. 4. The George Institute for Global Health, University of New South Wales Sydney, Sydney, Australia. 5. Departments of Medicine and brenda.hemmelgarn@ahs.ca.
Abstract
BACKGROUND: Urine albumin-to-creatinine ratio (ACR) and protein-to-creatinine ratio (PCR) are used to measure urine protein. Recent guidelines endorse ACR use, and equations have been developed incorporating ACR to predict risk of kidney failure. For situations in which PCR only is available, having a method to estimate ACR from PCR as accurately as possible would be useful. METHODS: We used data from a population-based cohort of 47,714 adults in Alberta, Canada, who had simultaneous assessments of urine ACR and PCR. After log-transforming ACR and PCR, we used cubic splines and quantile regression to estimate the median ACR from a PCR, allowing for modification by specified covariates. On the basis of the cubic splines, we created models using linear splines to develop equations to estimate ACR from PCR. In a subcohort with eGFR<60 ml/min per 1.73 m2, we then used the kidney failure risk equation to compare kidney failure risk using measured ACR as well as estimated ACR that had been derived from PCR. RESULTS: We found a nonlinear association between log(ACR) and log(PCR), with the implied albumin-to-protein ratio increasing from <30% in normal to mild proteinuria to about 70% in severe proteinuria, and with wider prediction intervals at lower levels. Sex was the most important modifier of the relationship between ACR and PCR, with men generally having a higher albumin-to-protein ratio. Estimates of kidney failure risk were similar using measured ACR and ACR estimated from PCR. CONCLUSIONS: We developed equations to estimate the median ACR from a PCR, optionally including specified covariates. These equations may prove useful in certain retrospective clinical or research applications where only PCR is available.
BACKGROUND: Urine albumin-to-creatinine ratio (ACR) and protein-to-creatinine ratio (PCR) are used to measure urine protein. Recent guidelines endorse ACR use, and equations have been developed incorporating ACR to predict risk of kidney failure. For situations in which PCR only is available, having a method to estimate ACR from PCR as accurately as possible would be useful. METHODS: We used data from a population-based cohort of 47,714 adults in Alberta, Canada, who had simultaneous assessments of urine ACR and PCR. After log-transforming ACR and PCR, we used cubic splines and quantile regression to estimate the median ACR from a PCR, allowing for modification by specified covariates. On the basis of the cubic splines, we created models using linear splines to develop equations to estimate ACR from PCR. In a subcohort with eGFR<60 ml/min per 1.73 m2, we then used the kidney failure risk equation to compare kidney failure risk using measured ACR as well as estimated ACR that had been derived from PCR. RESULTS: We found a nonlinear association between log(ACR) and log(PCR), with the implied albumin-to-protein ratio increasing from <30% in normal to mild proteinuria to about 70% in severe proteinuria, and with wider prediction intervals at lower levels. Sex was the most important modifier of the relationship between ACR and PCR, with men generally having a higher albumin-to-protein ratio. Estimates of kidney failure risk were similar using measured ACR and ACR estimated from PCR. CONCLUSIONS: We developed equations to estimate the median ACR from a PCR, optionally including specified covariates. These equations may prove useful in certain retrospective clinical or research applications where only PCR is available.
Authors: Navdeep Tangri; Morgan E Grams; Andrew S Levey; Josef Coresh; Lawrence J Appel; Brad C Astor; Gabriel Chodick; Allan J Collins; Ognjenka Djurdjev; C Raina Elley; Marie Evans; Amit X Garg; Stein I Hallan; Lesley A Inker; Sadayoshi Ito; Sun Ha Jee; Csaba P Kovesdy; Florian Kronenberg; Hiddo J Lambers Heerspink; Angharad Marks; Girish N Nadkarni; Sankar D Navaneethan; Robert G Nelson; Stephanie Titze; Mark J Sarnak; Benedicte Stengel; Mark Woodward; Kunitoshi Iseki Journal: JAMA Date: 2016-01-12 Impact factor: 56.272
Authors: Kunihiro Matsushita; Marije van der Velde; Brad C Astor; Mark Woodward; Andrew S Levey; Paul E de Jong; Josef Coresh; Ron T Gansevoort Journal: Lancet Date: 2010-05-17 Impact factor: 79.321
Authors: Shona Methven; Mark S MacGregor; Jamie P Traynor; Mario Hair; Denis St J O'Reilly; Christopher J Deighan Journal: Am J Kidney Dis Date: 2010-10-16 Impact factor: 8.860
Authors: Emily B Schroeder; Xiuhai Yang; Micah L Thorp; Brent M Arnold; David C Tabano; Amanda F Petrik; David H Smith; Robert W Platt; Eric S Johnson Journal: Clin J Am Soc Nephrol Date: 2016-12-27 Impact factor: 8.237
Authors: Aminu K Bello; Brenda Hemmelgarn; Anita Lloyd; Matthew T James; Braden J Manns; Scott Klarenbach; Marcello Tonelli Journal: Clin J Am Soc Nephrol Date: 2011-04-28 Impact factor: 8.237
Authors: Hude Quan; Nadia Khan; Brenda R Hemmelgarn; Karen Tu; Guanmin Chen; Norm Campbell; Michael D Hill; William A Ghali; Finlay A McAlister Journal: Hypertension Date: 2009-10-26 Impact factor: 10.190
Authors: Malcolm P McTaggart; Paul E Stevens; Christopher P Price; Ronald G Newall; Roger G Pinnock; Edmund J Lamb Journal: Clin Chem Lab Med Date: 2013-10 Impact factor: 3.694
Authors: Simon D S Fraser; Paul J Roderick; Natasha J McIntyre; Scott Harris; Christopher McIntyre; Richard Fluck; Maarten W Taal Journal: PLoS One Date: 2014-05-27 Impact factor: 3.240
Authors: William P Martin; Chloe Conroy; Serika D Naicker; Sarah Cormican; Tomás P Griffin; Md Nahidul Islam; Eibhlin M McCole; Ivan McConnell; John Lamont; Peter FitzGerald; John P Ferguson; Ciarán Richardson; Susan E Logue; Matthew D Griffin Journal: Kidney360 Date: 2021-05-21
Authors: Aksharaa Anpalahan; Eva Malacova; Katharine Hegerty; Andrew Malett; Dwarakanathan Ranganathan; Helen G Healy; Pedro Henrique Franca Gois Journal: Kidney360 Date: 2021-06-16
Authors: Michael F Schneider; Alvaro Muñoz; Elaine Ku; Bradley A Warady; Susan L Furth; George J Schwartz Journal: Am J Kidney Dis Date: 2020-09-06 Impact factor: 8.860
Authors: Christine Y Bakhoum; Kim T Vuong; Caitlin E Carter; Francis B Gabbai; Joachim H Ix; Pranav S Garimella Journal: Pediatr Res Date: 2021-01-27 Impact factor: 3.756
Authors: Keiichi Sumida; Girish N Nadkarni; Morgan E Grams; Yingying Sang; Shoshana H Ballew; Josef Coresh; Kunihiro Matsushita; Aditya Surapaneni; Nigel Brunskill; Steve J Chadban; Alex R Chang; Massimo Cirillo; Kenn B Daratha; Ron T Gansevoort; Amit X Garg; Licia Iacoviello; Takamasa Kayama; Tsuneo Konta; Csaba P Kovesdy; James Lash; Brian J Lee; Rupert W Major; Marie Metzger; Katsuyuki Miura; David M J Naimark; Robert G Nelson; Simon Sawhney; Nikita Stempniewicz; Mila Tang; Raymond R Townsend; Jamie P Traynor; José M Valdivielso; Jack Wetzels; Kevan R Polkinghorne; Hiddo J L Heerspink Journal: Ann Intern Med Date: 2020-07-14 Impact factor: 25.391